Samuel Belok, MD
Andrew E. Budson, MD
Amy Clouse, MD, FAAFP
Lisa M. Ferreira, MD, FOMA, DABOM, DABL
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Jennifer B. Green, MD
Stephen N. Henry, DO, MS
Jacob H. Johnson, MD
Jonette Keri, MD, PhD
Pamela Kushner, MD, FAAFP
Petros Levounis, MD, MA
Peter Lin, MD, CCFP
Vani Potluri, MD, DABOM
Jeffrey Rado, MD, MPH, FAPA
Charles Vega, MD, FAAFP
Disclosures
The following financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute. Relevant relationships will be disclosed at the start of each presentation.
Financial Disclosures
- Samuel Belok, MD
- No relevant financial relationships disclosed
- Andrew E. Budson, MD
- Advisor: AbbVie, Eli Lilly; Consultant: Eli Lilly; Speaker: Eli Lilly; Researcher: Vox Neuro, Eisai
- Amy Clouse, MD, FAAFP
- Stock Holder (publicly traded company): Eli Lilly and Novo Nordisk Inc.
- Lisa M. Ferreira, MD, FOMA, DABOM, DABL
- Speaker: Eli Lilly and Novo Nordisk Inc.
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Consultant: OptumRx
- Jennifer B. Green, MD
- Consultant: Anji, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Merck, Novo Nordisk, Valo, Vertex, Vertex; Researcher: Bluedrop, Boehringer Ingelheim, Merck, Roche
- Stephen N. Henry, DO, MS
- No relevant financial relationships disclosed.
- Jacob H. Johnson, MD
- No relevant financial relationships disclosed
- Jonette Keri, MD, PhD
- Advisor: Almirall; Advisor: Sanofi
- Pamela Kushner, MD, FAAFP
- Advisor: GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novo Nordisk, Lilly, Bausch/SALIX, Haleon, Verdiva, Abbott, Corcept, and Bayer; Speaker: GlaxoSmithKline, Boehringer Ingelheim, Phathom, AstraZeneca, Novo Nordisk, Lilly, Janssen, Haleon, Corcept, and Lilly
- Petros Levounis, MD, MA
- No relevant financial relationships disclosed
- Peter Lin, MD, CCFP
- Speaker: Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eisai, Eli Lilly, GlaxoSmithKline, Medtronic, Merck, Moderna, Novo Nordisk, Pfizer, Sanofi
- Vani Potluri, MD, DABOM
- No relevant financial relationships disclosed.
- Jeffrey Rado, MD, MPH, FAPA
- Speaker: Alkermes, Axsome Therapeutics, Bristol Myers Squibb; Independent Contractor: Bristol Myers Squibb, Johnson & Johnson, ALTO Neurosciences, Cerevel, Teva, Neurocrine, Relmada, Neurorelief, Click Therapeutics, NRX Pharmaceuticals
- Charles Vega, MD, FAAFP
- Consultant: GlaxoSmithKline, Boehringer Ingelheim, Exact Sciences
Other Disclosures
All relevant relationships have been mitigated by Pri-Med Institute. All other non-faculty contributors involved in the moderating, planning, development, editing and review of the content have disclosed no relevant financial relationships.